Drugmaker Novartis plans to spend $23 billion at 10 of its U.S. facilities, as the pharma industry grapples with Trump’s tariffs on imports.

The pharmaceutical industry is bracing for chaos if President Trump follows through on his threat to impose “a major tariff” ...

Swiss pharmaceutical giant Novartis said it plans to invest $23 billion in the construction and expansion of U.S. facilities, ...

By Patrick Wingrove (Reuters) -Swiss drugmaker Novartis said on Thursday it plans to spend $23 billion to build and expand 10 ...

President Trump said Tuesday his administration soon would announce “major” tariffs on pharmaceuticals, adding to the tariffs ...

The exemption may be short-lived if President Trump makes good on threats to use tariffs as leverage to bring drug production ...

As work progresses on an up-and-coming biologics plant in North Carolina, specialty pharma company Kyowa Kirin has completed ...

The Budget Lab at Yale, a nonpartisan policy research center, told ABC News that a 25% tariff would raise pharmaceutical ...

President Donald Trump said Tuesday that pharmaceutical imports will soon be hit with “major” tariffs as part of his efforts ...

Some of the country's largest drugmakers could be impacted by President Donald Trump's reciprocal tariffs, announced on ...

while other countries purchase the same drugs from the same pharma plants at lower prices. INDONESIA, OTHER COUNTRIES COME TO TRUMP TARIFF NEGOTIATING TABLE "We don't make our own ...

Japanese health officials searched a Kobayashi Pharmaceutical Co. plant in Osaka following reports of five deaths linked to its cholesterol-lowering supplements using red yeast. The factory was ...